SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-21-066222
Filing Date
2021-11-22
Accepted
2021-11-22 19:39:30
Documents
2
Period of Report
2021-11-19

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1541
2 POA DOCUMENT poa.txt EX-24 2003
  Complete submission text file 0001209191-21-066222.txt   4950
Mailing Address C/O MYOKARDIA, INC. 333 ALLERTON AVE SOUTH SAN FRANCISCO CA 94080
Business Address
Lee June (Reporting) CIK: 0001696493 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40656 | Film No.: 211434248

Mailing Address 171 OYSTER POINT BLVD., SUITE 500 SOUTH SAN FRANCISCO CA 94080
Business Address 171 OYSTER POINT BLVD., SUITE 500 SOUTH SAN FRANCISCO CA 94080 415-865-2066
Tenaya Therapeutics, Inc. (Issuer) CIK: 0001858848 (see all company filings)

IRS No.: 813789973 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences